Diabetes prevention program found to improve quality and reduces healthcare costs. It will now be covered by Medicare in 2017.
FDA issued a draft guidance to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF), while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-...
Spending on brand name drugs spiked 16.2% in 2015 and 98.2% since 2011, according to a new report from pharmacy benefit manager (PBM) Express Scripts. Plus, a third of branded products experienced price increases greater than 20% in...

AbbVie to profit from new Viekira Pak uses

FDA expanded the use of ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets without ribavirin (Viekira ...

Why FDA pulled cholesterol drugs off market
FDA committee recommends approving rare liver disease drug
New leukemia drug available